Koers Oncologix Tech, Inc. Other OTC
Aandelen
OCLG
US68230M2098
Holdingvennootschappen
Omzet 2013 | 0,24 0,22 | Omzet 2014 | 3,68 3,38 | Marktkapitalisatie | 758K 698K |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | - 0 | Nettowinst (verlies) 2014 | -1 mln. -920K | EV/omzet 2013 | 8.716.069 x |
Nettoschuld 2013 | 1,33 mln. 1,22 mln. | Nettoschuld 2014 | 1,89 mln. 1,74 mln. | EV/omzet 2014 | 721.342 x |
K/w-verhouding 2013 |
-1,03
x | K/w-verhouding 2014 |
-0,47
x | Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 25-06-21 |
Nikole Jessie
IRO | Public Communications Contact | - | 01-06-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 25-06-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+190,94% | 6,96 mld. | |
+2,14% | 982 mln. | |
+41,91% | 872 mln. | |
+26,98% | 830 mln. | |
+1,72% | 664 mln. | |
+5,92% | 642 mln. | |
-.--% | 600 mln. | |
+3,61% | 503 mln. | |
-.--% | 500 mln. |